The merger of Dow and DuPont, the acquisition of Syngenta by Chem- China, and the acquisition of Monsanto by Bayer have recently reshaped the global seed and biotech industry and caused concern about growing mar- ket concentration. This review documents market concentration in seed and agricultural biotech markets and discusses its causes and impacts. The avail- able evidence suggests that concentration in seed markets varies strongly by crop and by country, while markets for biotech traits are considerably more concentrated.
More than 250 million Africans rely on the starchy root crop cassava (Manihot esculenta) as their staple source of calories. A typical cassava-based diet, however, provides less than 30% of the minimum daily requirement for protein and only 10%–20% of that for iron, zinc, and vitamin A. The BioCassava Plus (BC+) program has employed modern biotechnologies intended to improve the health of Africans through the development and delivery of genetically engineered cassava with increased nutrient (zinc, iron, protein, and vitamin A) levels.